#Phage_therapy
LightNews LightNews
razizian65.bsky.social
🔬 Reza Azizian, Ph.D. | Experimental Phage Biologist

🦠 #Phage_therapy & #Salmonella cocktails
🧬 RPA-ELISA #molecular_diagnostics
🔬 Phage-host interactions & antibiofilm research

🎯 Seeking postdoctoral opportunities and collaborations in #phage_biology and NGS antimicrobials.
November 4, 2026 at 4:54 AM
haravanews.bsky.social
University of Utah researchers discovered that phage enzymes cut a bacterial sensor to trigger CBASS immunity and cell self-destruction.
[AI-generated]

#science#university_of_utah#bacteriophages#cbass_immunity#phage_therapy#bacterial_defense
University of Utah Researchers Show How Phage Enzymes Trigger Bacterial Immune Self-Destruction
University of Utah researchers discovered that phage enzymes cut a bacterial sensor to trigger CBASS immunity and cell self-destruction.
harava.news
October 10, 2026 at 11:00 AM
newsen.bsky.social
Exploring Armata Pharmaceuticals' Latest Insights on Phage Biology for Antibacterial Development#USA#Los_Angeles#biotechnology#phage_therapy#Armata_Pharmaceuticals
Exploring Armata Pharmaceuticals' Latest Insights on Phage Biology for Antibacterial Development
Armata Pharmaceuticals unveils a critical study enhancing the understanding of phage biology, vital for creating next-gen antibacterial therapies. Discover the findings!
third-news.com
September 3, 2026 at 11:20 AM
newsen.bsky.social
New Insights into Bacteriophage Structure: Armata Pharmaceuticals' Latest Publication#USA#Los_Angeles#phage_therapy#Armata_Pharmaceuticals#Pseudomonas_aeruginosa
New Insights into Bacteriophage Structure: Armata Pharmaceuticals' Latest Publication
Armata Pharmaceuticals has unveiled a groundbreaking paper on phage P7-1 that outlines its structural properties and relevance for antibiotic therapies.
third-news.com
May 4, 2026 at 11:20 AM
newsen.bsky.social
Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology#USA#Los_Angeles#phage_therapy#Armata_Pharmaceuticals#Pa223
Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology
Armata Pharmaceuticals has shared groundbreaking research on phage Pa223, highlighting its potential in treating chronic bacterial infections. This study opens doors for innovative therapeutic solutions.
third-news.com
September 8, 2025 at 11:15 AM
newsen.bsky.social
Armata Pharmaceuticals Reports Q4 and Full-Year 2024 Financial Results and Updates on Clinical Progress#USA#Los_Angeles#phage_therapy#Armata_Pharmaceuticals#AP-PA02
Armata Pharmaceuticals Reports Q4 and Full-Year 2024 Financial Results and Updates on Clinical Progress
Armata Pharmaceuticals shares its fourth quarter and full-year 2024 financial results, revealing significant clinical trial progress and a new funding agreement.
third-news.com
March 20, 2025 at 10:01 PM
newsen.bsky.social
Diverse Phage Populations Uncovered in Gut Bacteria to Combat Infections#United_States#New_York#E._coli#NYU_Grossman#phage_therapy
Diverse Phage Populations Uncovered in Gut Bacteria to Combat Infections
A groundbreaking study reveals how phages interact within gut bacteria, paving the way for innovative treatments against antibiotic-resistant infections, showcasing their ecological roles.
third-news.com
December 12, 2024 at 7:10 PM